Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valentina Fermanelli"'
Autor:
Hidefumi, Kasai, Kim Linda, Poppenberg, Valentina, Fermanelli, Yuki, Otani, Yusuke, Tanigawara
Publikováno v:
Therapeutic Drug Monitoring. 45:318-326
Neutropenia is a major dose-limiting toxicity of cancer chemotherapy. Semi-mechanistic mathematical models have been applied to describe the time course of neutrophil counts. The objectives of this study were to develop a mathematical model describin
Autor:
Martin Adiels, Kimmo Porthan, Johannes Fuchs, Annika Thorsell, Niina Matikainen, Sanni Söderlund, Valentina Fermanelli, Jan Borén, Linda Andersson, Chris J. Packard, Antti Hakkarainen, Mari Ainola, Florian Kronenberg, Marja-Riitta Taskinen, Juhani Kahri, Nina Lundbom, Elias Björnson
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 41(2)
Objective: Increased risk of atherosclerotic cardiovascular disease in subjects with type 2 diabetes is linked to elevated levels of triglyceride-rich lipoproteins and their remnants. The metabolic effects of PCSK9 (proprotein convertase subtilisin/k
Autor:
Valentina Fermanelli, Yusuke Tanigawara, Yukinori Sakata, Hidefumi Kasai, Toshiaki Takahashi, Toshiyuki Matsuoka, Mika Ishii, Takahisa Kawamura
Publikováno v:
Cancer Science
Postmarketing surveillance is useful to collect safety data in real‐world clinical settings. In this study, we applied postmarketing real‐world data on a mechanistic model analysis for neutropenic profiles of eribulin in patients with recurrent o
Autor:
Toshiaki Takahashi, Toshiyuki Matsuoka, Takahisa Kawamura, Valentina Fermanelli, Yukinori Sakata, Mika Ishii, Yusuke Tanigawara
Publikováno v:
Cancer Research. 77:5052-5052
Background: Japanese regulation imposes a mandatory post-marketing observational cohort study for new chemical entities and biological products. The primary purpose is collection of safety data in actual clinical settings by an active surveillance ap